News summary

Orthotopic liver xenotransplantation from gene-modified pig to decedent human

Source: Nature - Biotechnology • Published: 16 Sept 2026, 00:00

Summarized by Masters of Longevity from Nature - Biotechnology.

Reports an orthotopic gene‑modified pig-to-human liver transplant in a brain‑dead donor, tracking graft function, coagulation, and immune responses over 11 days.

Orthotopic liver xenotransplantation from gene-modified pig to decedent human
Key Takeaways
  • The xenograft produced continuous albumin and bile with normal composition for 11 days, but at relatively low levels.
  • Progressive thrombocytopenia and reduced clotting factor activity developed alongside microthrombosis and suboptimal hepatic perfusion.
  • Histology showed minimal T and B cell infiltration but strong innate activation with IgM-mediated complement deposition.
Read the full article at Nature - Biotechnology

Continue exploring

Recommended MoL Picks

MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.